UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cell death‐independent activities of the death receptors CD95, TRAILR1, and TRAILR2

The FEBS journal, 2017-04, Vol.284 (8), p.1131-1159

2017

Volltextzugriff (PDF)

FcγRs and Their Relevance for the Activity of Anti-CD40 Antibodies

International journal of molecular sciences, 2022-11, Vol.23 (21), p.12869

2022

Volltextzugriff (PDF)

Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily

Frontiers in immunology, 2023-03, Vol.14, p.1115667-1115667

2023

Volltextzugriff (PDF)

Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies

Frontiers in immunology, 2018-04, Vol.9, p.793-793

2018

Volltextzugriff (PDF)

Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells

The Journal of biological chemistry, 2016-03, Vol.291 (10), p.5022-5037

2016

Volltextzugriff (PDF)

Membrane lymphotoxin-α2β is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist

Cell death & disease, 2021-04, Vol.12 (4), p.360-360, Article 360

2021

Volltextzugriff (PDF)

A TNFR2-Specific TNF Fusion Protein With Improved In Vivo Activity

Frontiers in immunology, 2022-06, Vol.13, p.888274-888274

2022

Volltextzugriff (PDF)

Corrigendum: A TNFR2-specific TNF fusion protein with improved in vivo activity

Frontiers in immunology, 2023-12, Vol.14, p.1352525-1352525

2023

Volltextzugriff (PDF)

Complement 1q/Tumor Necrosis Factor-Related Proteins (CTRPs): Structure, Receptors and Signaling

Biomedicines, 2023-02, Vol.11 (2), p.559

2023

Volltextzugriff (PDF)

TWEAK inhibits TRAF2-mediated CD40 signaling by destabilization of CD40 signaling complexes

The Journal of immunology (1950), 2013-09, Vol.191 (5), p.2308-2318

2013

Volltextzugriff (PDF)

Tumor necrosis factor induces tumor promoting and anti-tumoral effects on pancreatic cancer via TNFR1

PloS one, 2013-09, Vol.8 (9), p.e75737

2013

Volltextzugriff (PDF)

Exogenous administration of a recombinant variant of TWEAK impairs healing after myocardial infarction by aggravation of inflammation

PloS one, 2013-11, Vol.8 (11), p.e78938-e78938

2013

Volltextzugriff (PDF)

A Novel Tetravalent CD95 /Fas Fusion Protein With Superior CD95L / FasL Antagonism

Proteins, structure, function, and bioinformatics, 2024-09

2024

Volltextzugriff (PDF)

A systems-biology model of the tumor necrosis factor (TNF) interactions with TNF receptor 1 and 2

Bioinformatics, 2021-05, Vol.37 (5), p.669-676

2021

Volltextzugriff (PDF)

Cell death‐independent activities of the death receptors CD 95, TRAILR 1, and TRAILR 2

The FEBS journal, 2017-04, Vol.284 (8), p.1131-1159

2017

Volltextzugriff (PDF)

Generation and Application of Bioluminescent CD95 Ligand Fusion Proteins

Methods in molecular biology (Clifton, N.J.), 2017-01, Vol.1557, p.63

2017

Volltextzugriff (PDF)

Genetically engineered IgG1 and nanobody oligomers acquire strong intrinsic CD40 agonism

Bioengineered, 2024-12, Vol.15 (1), p.2302246-2302246

2024

Volltextzugriff (PDF)

Correction: Binding studies of TNF receptor superfamily (TNFRSF) receptors on intact cells

The Journal of biological chemistry, 2020-08, Vol.295 (32), p.11377-11377

2020

Volltextzugriff (PDF)

Systemic treatment with a selective TNFR2 agonist alters the central and peripheral immune responses and transiently improves functional outcome after experimental ischemic stroke

Journal of neuroimmunology, 2023-12, Vol.385, p.578246-578246, Article 578246

2023

Volltextzugriff (PDF)

Harnessing the Expression of TNFR2 on Tregs to Prevent Agvhd

Blood, 2022-11, Vol.140 (Supplement 1), p.4465-4466

2022

Volltextzugriff (PDF)

Studies of Binding of Tumor Necrosis Factor (TNF)-like Weak Inducer of Apoptosis (TWEAK) to Fibroblast Growth Factor Inducible 14 (Fn14)

The Journal of biological chemistry, 2012-01, Vol.287 (1), p.484-495

2012

Volltextzugriff (PDF)

Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors

Oncogene, 2018-07, Vol.37 (30), p.4122-4136

2018

Volltextzugriff (PDF)

Signaling Active CD95 Receptor Molecules Trigger Co-translocation of Inactive CD95 Molecules into Lipid Rafts

The Journal of biological chemistry, 2012-07, Vol.287 (28), p.24026-24042

2012

Volltextzugriff (PDF)

Generic design principles for antibody-based tumour necrosis factor (TNF) receptor 2 (TNFR2) agonists with FcγR-independent agonism

Theranostics, 2024, Vol.14 (2), p.496-509

2024

Volltextzugriff (PDF)

Membrane lymphotoxin-α 2 β is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist

Cell death & disease, 2021-04, Vol.12 (4), p.360

2021

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(89)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(37)
Humans
(21)
History Of Art & Design Styles: From C 1900
(16)
The Arts: General Issues
(16)
Biochemistry & Molecular Biology
(11)
Animals
(9)
Apoptosis
(8)
Immunology
(8)
Mice
(7)
Proteins
(7)
Tumor Necrosis Factor
(7)
Female
(6)
Hek293 Cells
(6)
Signal Transduction
(6)
Tumor Necrosis Factor-Tnf
(6)
Cell Line, Tumor
(5)
Male
(5)
Psychology
(5)
Receptors, Tumor Necrosis Factor - Metabolism
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cell death‐independent activities of the death receptors CD95, TRAILR1, and TRAILR2

FcγRs and Their Relevance for the Activity of Anti-CD40 Antibodies

Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily

Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies

Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells

Membrane lymphotoxin-α2β is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist

A TNFR2-Specific TNF Fusion Protein With Improved In Vivo Activity

Corrigendum: A TNFR2-specific TNF fusion protein with improved in vivo activity

Complement 1q/Tumor Necrosis Factor-Related Proteins (CTRPs): Structure, Receptors and Signaling

TWEAK inhibits TRAF2-mediated CD40 signaling by destabilization of CD40 signaling complexes

Tumor necrosis factor induces tumor promoting and anti-tumoral effects on pancreatic cancer via TNFR1

Exogenous administration of a recombinant variant of TWEAK impairs healing after myocardial infarction by aggravation of inflammation

A Novel Tetravalent CD95 /Fas Fusion Protein With Superior CD95L / FasL Antagonism

A systems-biology model of the tumor necrosis factor (TNF) interactions with TNF receptor 1 and 2

Cell death‐independent activities of the death receptors CD 95, TRAILR 1, and TRAILR 2

Generation and Application of Bioluminescent CD95 Ligand Fusion Proteins

Genetically engineered IgG1 and nanobody oligomers acquire strong intrinsic CD40 agonism

Correction: Binding studies of TNF receptor superfamily (TNFRSF) receptors on intact cells

Systemic treatment with a selective TNFR2 agonist alters the central and peripheral immune responses and transiently improves functional outcome after experimental ischemic stroke

Harnessing the Expression of TNFR2 on Tregs to Prevent Agvhd

Studies of Binding of Tumor Necrosis Factor (TNF)-like Weak Inducer of Apoptosis (TWEAK) to Fibroblast Growth Factor Inducible 14 (Fn14)

Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors

Signaling Active CD95 Receptor Molecules Trigger Co-translocation of Inactive CD95 Molecules into Lipid Rafts

Generic design principles for antibody-based tumour necrosis factor (TNF) receptor 2 (TNFR2) agonists with FcγR-independent agonism

Membrane lymphotoxin-α 2 β is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist

Suchergebnisse filtern